Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ofloxacin Concentration-toxicity Relationship in the Elderly
Sponsor: Centre Hospitalier Universitaire, Amiens
Summary
Ofloxacin is a gold standard antibiotic for the treatment of bone and joint infections due to sensible staphylococcus strains. However, in the elderly, inter-individual variability of the pharmacokinetics may reduce the efficacy or increase toxicity. The occurrence of ofloxacin side effects is likely to be increased in case of higher exposition. However, the serum concentration-toxicity relationship has not yet been determined. The purpose of this project is to assess the association between the residual serum concentration of ofloxacin at day 3 and the occurrence of at least one adverse effect attributable to ofloxacin, and determine a threshold toxicity concentration if this association exists.
Official title: Determination of a Trough Serum Concentration of Ofloxacin Associated to Increase in Side Effects Frequency in Elderly Treated for Bone and Joint Infection
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
110
Start Date
2020-06-02
Completion Date
2026-08
Last Updated
2025-06-10
Healthy Volunteers
No
Interventions
ofloxacin
ofloxacin treatment in patients with bone and joint infections
questionnaire
questionnaire of ofloxacine side effects will be completed by the clinician at Day 3, Day 21 and Day 42
Ofloxacin Serum concentration
Serum concentration of ofloxacin will be measured at Day 3 (Cmin and Cmax), Day 21 and Day 42 (Cmin).
Locations (1)
CHU Amiens
Amiens, France